T cell interactions with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy

被引:11
作者
Bednarczuk, T [1 ]
Kiljanski, J [1 ]
Mrowiec, T [1 ]
Slon, M [1 ]
Ing, E [1 ]
Stolarski, C [1 ]
Kennerdell, JS [1 ]
Gorski, A [1 ]
Nauman, J [1 ]
Wall, JR [1 ]
机构
[1] Polish Acad Sci, Med Res Ctr, Dept Endocrinol, PL-02097 Warsaw, Poland
关键词
thyroid-associated ophthalmopathy; T lymphocyte; collagen; fibronectin; laminin;
D O I
10.3109/08916939808993834
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although thyroid-associated ophthalmopathy (TAO) is now generally accepted as an autoimmune inflammatory disorder of the extraocular muscles and the orbital connective tissue, its aetiopathogenesis remains poorly understood. Recent data indicate that impaired interactions between T cells and extracellular matrix (ECM) proteins may play an important role in development and maintaining of an inflammatory process. We report here results of the study focusing on interactions between T lymphocytes and collagen-I (Coll-I), collagen-IV (doll-IV), fibronectin (FN), laminin (LM) in patients with TAO. Using a standard peripheral blood mononuclear cells (PBMC) proliferation assay, we observed a markedly enhanced T cell response to Coll-I in patients with active TAO (mean SI = 4.5). The proliferatory response to Coll-I was significantly greater (Wilcoxon test; p < 0.001) than in normal subjects (mean SI = 1.88), patients with stable TAO (mean SI = 2.05) and patients with thyroid autoimmune diseases (AITD) without ophthalmopathy (mean SI = 2.49), PBMC stimulation by Coll-I is likely to be antigen-dependent requiring engagement of the T cell receptor with collagen peptides, rather than mediated via integrins. The percentage of circulating CD29(+) (beta 1 integrin chain) T cells war; not increased in patients with active TAO. Additionally in the assay of costimulation of CD3-mediated proliferation, we found that peripheral blood T cells from patients with TAO and AITD were costimulated only by FN, On the other hand a markedly enhanced costimulation of CD3-mediated proliferative responses by Coll-I, Coll-IV, FN and LM were observed in a retrobulbar T cell line. We conclude that abnormalities in T cell interactions with ECM proteins, especially Coll-I may play a role in the pathogenesis of TAO.
引用
收藏
页码:221 / 230
页数:10
相关论文
共 39 条
[1]   THE FIBROBLAST IS THE TARGET-CELL IN THE CONNECTIVE-TISSUE MANIFESTATIONS OF GRAVES-DISEASE [J].
BAHN, RS .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 106 (03) :213-218
[2]  
BEDNARCZUK T, 1996, THYROID, V6, pS67
[3]  
BEDNARCZUK T, IN PRESS THYROID DIS
[4]   GRAVES OPHTHALMOPATHY - CURRENT CONCEPTS REGARDING PATHOGENESIS AND MANAGEMENT [J].
BURCH, HB ;
WARTOFSKY, L .
ENDOCRINE REVIEWS, 1993, 14 (06) :747-793
[5]   ROLE OF CELLULAR AND EXTRACELLULAR-MATRIX ADHESION PROTEINS IN ORGAN-TRANSPLANTATION [J].
COITO, AJ ;
DESOUSA, M ;
KUPIECWEGLINSKI, JW .
CELL ADHESION AND COMMUNICATION, 1994, 2 (03) :249-255
[6]   HUMAN CD4 HELPER T-CELL ACTIVATION - FUNCTIONAL INVOLVEMENT OF 2 DISTINCT COLLAGEN RECEPTORS, 1F7 AND VLA INTEGRIN FAMILY [J].
DANG, NH ;
TORIMOTO, Y ;
SCHLOSSMAN, SF ;
MORIMOTO, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (02) :649-652
[7]  
GARCIAVICUNA R, 1992, CLIN EXP IMMUNOL, V88, P435
[8]   Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix [J].
Gilat, D ;
Cahalon, L ;
Hershkoviz, R ;
Lider, O .
IMMUNOLOGY TODAY, 1996, 17 (01) :16-20
[9]   ALTERATIONS OF T-CELL-EXTRACELLULAR MATRIX PROTEINS INTERACTIONS IN PSORIASIS [J].
GLINSKI, W ;
STEPIENSOPNIEWSKA, B ;
MAJEWSKI, S ;
GLINSKAFERENZ, M ;
GORSKI, A .
IMMUNOLOGY LETTERS, 1993, 35 (02) :153-158
[10]   DEPRESSED IMMUNE SURVEILLANCE AGAINST CANCER - ROLE OF DEFICIENT T-CELL - EXTRACELLULAR-MATRIX INTERACTIONS [J].
GORSKI, A ;
CASTRONOVO, V ;
STEPIENSOPNIEWSKA, B ;
GRIEB, P ;
RYBA, M ;
MROWIEC, T ;
KORCZAKKOWALSKA, G ;
WIERZBICKI, P ;
MATYSIAK, W ;
DYBOWSKA, B ;
PIEKARCZYK, J ;
GAWALKIEWICZ, J ;
KRYST, P ;
BORKOWSKI, A ;
TOLLOCZKO, T .
CELL ADHESION AND COMMUNICATION, 1994, 2 (03) :225-233